Vector(s) containing an inducible gene encoding a CDK4/CDK6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle

Details for Australian Patent Application No. 2010211289 (hide)

Owner Universitat Leipzig

Inventors Arendt, Thomas; Ueberham, Uwe

Agent Spruson & Ferguson

Pub. Number AU-A-2010211289

PCT Pub. Number WO2010/089122

Priority 09001521.5 04.02.09 EP

Filing date 4 February 2010

Wipo publication date 12 August 2010

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/089122 Priority application(s): WO2010/089122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010211291-Layer structure and films for ID documents having improved properties for laser engraving

2010211285-Spring system for roller blinds